market PolyHeme commercially

Related by string. * marketing . markets . Marketing . marketed : MARKET WIRE via COMTEX . RBC Capital Markets . Stock Market . BMO Capital Markets / Polyheme : render PolyHeme obsolete . PolyHeme successfully . substitute PolyHeme . PolyHeme ® / Commercially : cellulosic ethanol commercially viable . commercially astute . commercially viable quantities . commercially viable microturbine * *

Related by context. Frequent words. (Click for all words.) 58 Somaxon ability 58 free E Newsletters 56 TranSwitch indebtedness 55 regulatory authorizations 55 Exelbine 54 website AARP.org 54 OFIRMEV 54 site www.buyins.net 53 Entereg R 52 Web site http:/www.EmergingStockReport.com 52 ZEGERID Capsules 52 UltiMAb R technology 52 Rotarix R 52 governmental approvals 52 Nortel strategic alliances 52 Cinryze TM 52 requisite regulatory approvals 52 Biologics License Application 52 supplemental Biologics License Application 52 Bioenvision compounds under 52 vernakalant oral 52 MGCD# MGCD# [002] 51 faropenem 51 SANCTURA R 51 BioThrax R 51 viii 51 PD2i Analyzer ™ 51 TOCOSOL Paclitaxel 51 Please visit www.covidien.com 51 By Priyanka Dayal 51 regulatory approvals 51 http:/www.nicusa.com 51 risks anduncertainties 51 Plenaxis R 50 R sorafenib tablets 50 stockholder approvals 50 TELINTRA 50 SILENOR TM 50 development diagnostics combinatorial 50 MONOVISC 50 Panzem R 50 successfully commercialize REOLYSIN 50 http:/www.b#i.us/irpass.asp?BzID=#&to=ea&s=# [002] 50 Therein lurks 50 Orphan Drug status 50 xxii 50 Reader Reaction These 50 By TheStreet Wire 50 should consult Cytokinetics 50 TranSwitch filings 50 MOZOBIL 49 forodesine 49 Rosetta dependence 49 Allovectin 7 R 49 Poly ICR 49 NEUMUNE 49 IoGen 49 growth acquisitions recapitalizations 49 party VLSI fabrication 49 vosaroxin 49 BLA submission 49 Neuro Hitech 49 pralatrexate 49 ELADUR 49 By Thomas Gryta 49 forodesine HCl 49 ELEVESS 49 Icatibant 48 Anturol 48 strategy summarization 48 DSL.net s 48 obtaining regulatory approvals 48 www.thallion.com 48 necessary regulatory approvals 48 bafetinib 48 BENLYSTA 48 www.norsat.com 48 PLIVA acquisition 48 Daytrana TM 48 strategy GlobalData summarization 48 FavId 48 refractory chronic lymphocytic 48 confirmatory Phase III 48 TRISENOX 48 xvii 48 Energy LLC DPLE 48 Application BLA 48 regulatory clearances 48 PREOS 48 obj obj = 48 Soliris TM eculizumab 48 Genitope Corporation 48 ADSI ability 48 Toosi reported 47 ZEGERID Powder 47 adverse determinations 47 Alnara 47 CPL Biologicals 47 Our PriceWatch Alerts 47 Supports relaxing 47 Fodosine TM

Back to home page